Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.
Charles S GoldsmithSam Moon KimNirmala KarunarathnaNichole NeuendorffL Gerard ToussaintDavid J EarnestDeborah Bell-PedersenPublished in: BMC cancer (2018)
Glioma treatment with p38 MAPK inhibitors may be more effective and less toxic if administered at the appropriate time of the day.
Keyphrases